CHOU Cheng-Yang | Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT
IS-20 Volume-activated taurine transport in human cervical cells with different tumor potential
IS-49 Loss of b type FGFR promote cell invasive ability- a possible role in cervical carcinogenesis(Group6 Oncology3,International Session)
IS-11 GnRH agonist-induced DNA damage on uterine leiomyomas is indirectly through estrogen suppression
IS-69 The Value of Preoperative Serum CA125 in Endometriosis Patient
Novel method for preoperative prediction of Gonadotropin releasing hormone agonist (GnRH-a) treatment response in uterine leiomyoma by 3D power Doppler ultrasonography(Oncology 13)
Serial follow up of uterine leiomyoma patient receiving GnRH-agonist with 3D power Doppler ultrasonography(Session15 Oncology7)
Enhanced Polyadenosine Diphosphate-ribosylation of Smooth Muscle Cells in GnRH Agonist-Treated Uterine Leio-myoma(Session6 Oncology6)
P-IS-17 Fibroblast growth factor receptor 1 (FGFR1) overexpression play a possible role in cervical carcinogenesis(Oncology 5,Group 92,International Session)
P1-IS-49 Hysteroscopy Examination in Women with Breast Cancer Receiving Tamoxifen
IS-105 Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy(Group13 Oncology5,International Session)
IS-72 Fas Ligand and Procaspase 3 Are Constitutively Expressed in Uterine Myometrium, Up-regulated in Leiomyoma and Down-regulated Following Gonadotropin Releasing Hormone Agonist Treatment

もっと見る

スポンサーリンク